Bio-imaging Market - Trends, Size & Outlook (2024-2032)

Bio-imaging Market Synopsis:

Bio-imaging Market Size Was Valued at USD 17.70 Billion in 2023 and is Projected to Reach USD 28.42 Billion by 2032, Growing at a CAGR of 5.40% From 2024-2032.

Bio-imaging Market on the other hand defines the market of products and services that are involved in using imaging to observe biological processes within living organisms. These technologies include Optical imaging; ultrasound imaging; Magnetic Resonance Imaging (MRI); computed imaging and tomography (CT); Radiography or X-ray imaging; and nuclear imaging. Bio-imaging plays a significant role in the diagnosis of diseases as well as in the study of the effectiveness of therapeutic treatment techniques, due to its combined structural and functional overview of biological systems at various levels of organization.

A primary growth stimulant in the Bio-imaging Market is catalogued by the higher incidence of chronic illnesses including cancer, heart attacks, and nervous system diseases. Due to increased aging of the general population across the world and increasing prevalence of lifestyle diseases, there is increasing demand for the improved diagnostic technologies used in diagnosing such conditions. Bio-imaging technologies provide non-penetrating and high-definition imaging skills which provide timely tactics to enhancer patients overlong.

Furthermore, there is significant growth in the adoption of the technology due to new imaging techniques. High resolution imaging, real time imaging, and use of artificial intelligence in image interpretation are features that are improving bio- imaging systems. These developments not only enhance the diagnostic capability but also maximize efficiency in clinical environment therefore making bio-imaging an important part of health care today.

Bio-imaging Market Trend Analysis:

The increasing adoption of hybrid imaging techniques.

• One of the trends the market has been witnessing is growth of hybrid imaging technologies. Multimodal PET/CT and PET/MRI integrate the best of two health imaging techniques to gain a clear picture of the biological processes taking place in the human body. This trend is caused by the necessity to obtain further detailed information for diagnosis and further treatment planning, especially in oncology and neurological indications.
• Another discernable trend is the increased importance of the idea of individualized therapy which requires individual approach to diagnostics and further intervention. Imaging biology contributes to this shift by visualising individual patient therapeutic response. Increasing the patient focused approach in the healthcare industry will further step up the necessity of relying on hi-tech bio-imaging systems that offer specific data on the state of patients.

Healthcare infrastructure is rapidly developing.

• This is a promising market for development since many countries around the world today are focusing on the advancement of their healthcare system. With such regions emerging economies opting for better diagnostic equipment, there is always a huge market for bio-imaging solutions that will improve on disease diagnosis. These regions offer huge market potential for firms which are able to offer affordable imaging technologies.
• However, the upcoming advancement in the molecular imaging research can be considered as potentiality for innovation. Current research relating to molecular imaging, processes that permit the visualisation of cellular and molecular events, are gradually gaining higher significance in pharmacological studies and disease diagnosis. Companies that support the research and development of molecular imaging techniques are equipped with prospective market opportunities and the future of the molecular medicine.

Bio-imaging Market Segment Analysis:

Bio-imaging Market is Segmented on the basis of Type, Application, End User, and Region

By Type, Optical Imaging segment is expected to dominate the market during the forecast period

• •By type, segments of the Bio-imaging Market are differentiated based on the imaging specialties that address different diagnostic and research applications. Optical imaging means the illumination of the tissues in question in order to take pictures of the tissues with the view of observing the cellular processes in the tissues in real time. Most ultrasound imaging techniques are non-invasive since they involve using sound waves to build up picture of internal organs and tissues. MRI is employed in neurological and musculoskeletal imaging, is a general technique that utilizes strong magnetic field, as well as radio-waveform to construct images of the body’s soft tissues. Radiography is one of the oldest techniques that use radiation to produce images of the interior of the body and is usually used to assess for bone disorders amongst other. CT, or Computed Tomography involves making many X-ray images and making a broad picture of the interior area of the body part, of the bone or soft tissue type. The last on the list of diagnostic imaging is nuclear imaging which uses radioactive substances to produce images of structures within a human body, to diagnose diseases depending on how body organs or molecule’s function or do not function at all. All of these imaging types play considerable role for the purpose of improving the diagnostic as well as the treatment planning demands in the context of health.

By Application, Oncology segment expected to held the largest share

• • The Bio-imaging Market is also segmented by the application to assist the different medical sciences to fulfill their role.. In oncology, bio imaging plays a crucial role in early detection of tumor, diagnosis, treatment planning, assessment of treatments and evaluations of the therapeutic results. Imaging is also applied in cardiology so as to visually separate the heart and its operations in identifying health complications such as coronary artery disease and congestive heart failure. MRI, CT and other related scans are part and parcel of Neurology to identify the deficiencies in the brain, confirm specific neurological ailments or disorders and strategize further. Imaging is employed by orthopedists to identify the kind of bone/joint disorder and the severity of the condition; disorders that include fracture, arthritis and etc. In gastroenterology bio-imaging is applied in imaging of the lower and upper parts of the gastrointestinal canal for diagnostic purposes of the disease such as inflammatory bowel disease as well as the tumour. Moreover, for all the other fields or area, which is so differed as pediatric, urology, endocrinology, etc., it is disposed in “Other Applications” category since the bio-imaging is applied in almost all fields of medicine. All applications employ specific kinds of imaging to enhance the diagnostic accuracy, treatment outcomes, and the experiences of the patients.

Bio-imaging Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America continues to dominate the Bio-imaging Market because of an array of factors that include developed healthcare systems and a large population suffering from chronic diseases. High index of R&D and high expenditure on medical imaging technologies has put the region on the cutting-edge way of bio-imaging. Larger medical care organizations and research laboratories in North America are constantly improving imaging techniques, and therefore, the region takes the most significant share in the overall market.
• Moreover, there is the robust reimbursement model and standard regulatory framework system in North America for the uptake of sophisticated bio-imaging solutions. ubi sociopolitical – existence of key players within a specified region; synergos – collaborations between academic institutions and industry leading to favourable technological environments. Consequently, North America is expected to retain its leadership position in the Bio-imaging Market into the medium-term future.

Active Key Players in the Bio-imaging Market:

• Siemens Healthineers (Germany)
• GE Healthcare (United States)
• Philips Healthcare (Netherlands)
• Canon Medical Systems (Japan)
• Hitachi Medical Corporation (Japan)
• Fujifilm Holdings Corporation (Japan)
• Bracco Imaging (Italy)
• Mindray Medical International Limited (China)
• Carestream Health (United States)
• Agfa-Gevaert Group (Belgium)
• Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Bio-imaging Market by Product Type
 4.1 Bio-imaging Market Snapshot and Growth Engine
 4.2 Bio-imaging Market Overview
 4.3 Optical Imaging
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Optical Imaging: Geographic Segmentation Analysis
 4.4 Ultrasound Imaging
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Ultrasound Imaging: Geographic Segmentation Analysis
 4.5 MRI (Magnetic Resonance Imaging)
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 MRI (Magnetic Resonance Imaging): Geographic Segmentation Analysis
 4.6 X-ray Imaging
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 X-ray Imaging: Geographic Segmentation Analysis
 4.7 CT (Computed Tomography) Imaging
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 CT (Computed Tomography) Imaging: Geographic Segmentation Analysis
 4.8 Nuclear Imaging
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Nuclear Imaging: Geographic Segmentation Analysis

Chapter 5: Bio-imaging Market by Application
 5.1 Bio-imaging Market Snapshot and Growth Engine
 5.2 Bio-imaging Market Overview
 5.3 Oncology
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Oncology: Geographic Segmentation Analysis
 5.4 Cardiology
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Cardiology: Geographic Segmentation Analysis
 5.5 Neurology
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Neurology: Geographic Segmentation Analysis
 5.6 Orthopedics
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Orthopedics: Geographic Segmentation Analysis
 5.7 Gastroenterology
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Gastroenterology: Geographic Segmentation Analysis
 5.8 Other Applications
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Other Applications: Geographic Segmentation Analysis

Chapter 6: Bio-imaging Market by End User
 6.1 Bio-imaging Market Snapshot and Growth Engine
 6.2 Bio-imaging Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Diagnostic Imaging Centers
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Diagnostic Imaging Centers: Geographic Segmentation Analysis
 6.5 Research Institutes
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Research Institutes: Geographic Segmentation Analysis
 6.6 Other End Users
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Other End Users: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Bio-imaging Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 SIEMENS HEALTHINEERS (GERMANY)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 GE HEALTHCARE (UNITED STATES)
 7.4 PHILIPS HEALTHCARE (NETHERLANDS)
 7.5 CANON MEDICAL SYSTEMS (JAPAN)
 7.6 HITACHI MEDICAL CORPORATION (JAPAN)
 7.7 FUJIFILM HOLDINGS CORPORATION (JAPAN)
 7.8 BRACCO IMAGING (ITALY)
 7.9 MINDRAY MEDICAL INTERNATIONAL LIMITED (CHINA)
 7.10 CARESTREAM HEALTH (UNITED STATES)
 7.11 AGFA-GEVAERT GROUP (BELGIUM)
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global Bio-imaging Market By Region
 8.1 Overview
 8.2. North America Bio-imaging Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product Type
  8.2.4.1 Optical Imaging
  8.2.4.2 Ultrasound Imaging
  8.2.4.3 MRI (Magnetic Resonance Imaging)
  8.2.4.4 X-ray Imaging
  8.2.4.5 CT (Computed Tomography) Imaging
  8.2.4.6 Nuclear Imaging
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Oncology
  8.2.5.2 Cardiology
  8.2.5.3 Neurology
  8.2.5.4 Orthopedics
  8.2.5.5 Gastroenterology
  8.2.5.6 Other Applications
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Hospitals
  8.2.6.2 Diagnostic Imaging Centers
  8.2.6.3 Research Institutes
  8.2.6.4 Other End Users
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Bio-imaging Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product Type
  8.3.4.1 Optical Imaging
  8.3.4.2 Ultrasound Imaging
  8.3.4.3 MRI (Magnetic Resonance Imaging)
  8.3.4.4 X-ray Imaging
  8.3.4.5 CT (Computed Tomography) Imaging
  8.3.4.6 Nuclear Imaging
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Oncology
  8.3.5.2 Cardiology
  8.3.5.3 Neurology
  8.3.5.4 Orthopedics
  8.3.5.5 Gastroenterology
  8.3.5.6 Other Applications
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Hospitals
  8.3.6.2 Diagnostic Imaging Centers
  8.3.6.3 Research Institutes
  8.3.6.4 Other End Users
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
 8.4. Western Europe Bio-imaging Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product Type
  8.4.4.1 Optical Imaging
  8.4.4.2 Ultrasound Imaging
  8.4.4.3 MRI (Magnetic Resonance Imaging)
  8.4.4.4 X-ray Imaging
  8.4.4.5 CT (Computed Tomography) Imaging
  8.4.4.6 Nuclear Imaging
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Oncology
  8.4.5.2 Cardiology
  8.4.5.3 Neurology
  8.4.5.4 Orthopedics
  8.4.5.5 Gastroenterology
  8.4.5.6 Other Applications
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Hospitals
  8.4.6.2 Diagnostic Imaging Centers
  8.4.6.3 Research Institutes
  8.4.6.4 Other End Users
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
 8.5. Asia Pacific Bio-imaging Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product Type
  8.5.4.1 Optical Imaging
  8.5.4.2 Ultrasound Imaging
  8.5.4.3 MRI (Magnetic Resonance Imaging)
  8.5.4.4 X-ray Imaging
  8.5.4.5 CT (Computed Tomography) Imaging
  8.5.4.6 Nuclear Imaging
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Oncology
  8.5.5.2 Cardiology
  8.5.5.3 Neurology
  8.5.5.4 Orthopedics
  8.5.5.5 Gastroenterology
  8.5.5.6 Other Applications
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Hospitals
  8.5.6.2 Diagnostic Imaging Centers
  8.5.6.3 Research Institutes
  8.5.6.4 Other End Users
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Bio-imaging Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product Type
  8.6.4.1 Optical Imaging
  8.6.4.2 Ultrasound Imaging
  8.6.4.3 MRI (Magnetic Resonance Imaging)
  8.6.4.4 X-ray Imaging
  8.6.4.5 CT (Computed Tomography) Imaging
  8.6.4.6 Nuclear Imaging
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Oncology
  8.6.5.2 Cardiology
  8.6.5.3 Neurology
  8.6.5.4 Orthopedics
  8.6.5.5 Gastroenterology
  8.6.5.6 Other Applications
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Hospitals
  8.6.6.2 Diagnostic Imaging Centers
  8.6.6.3 Research Institutes
  8.6.6.4 Other End Users
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Bio-imaging Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product Type
  8.7.4.1 Optical Imaging
  8.7.4.2 Ultrasound Imaging
  8.7.4.3 MRI (Magnetic Resonance Imaging)
  8.7.4.4 X-ray Imaging
  8.7.4.5 CT (Computed Tomography) Imaging
  8.7.4.6 Nuclear Imaging
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Oncology
  8.7.5.2 Cardiology
  8.7.5.3 Neurology
  8.7.5.4 Orthopedics
  8.7.5.5 Gastroenterology
  8.7.5.6 Other Applications
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Hospitals
  8.7.6.2 Diagnostic Imaging Centers
  8.7.6.3 Research Institutes
  8.7.6.4 Other End Users
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research